Skip to content
Tech News
clear
Topics: Today This Week This Month This Year
181.
The Next Acetaminophen Tablet You Take Could Be Made From PET (wired.com)
182.
Spike in Pancreas Problems From Weight-Loss Drugs Prompts Investigation (gizmodo.com)
183.
OpenAI vs. iyO: Key takeaways from the new legal filings (9to5mac.com)
184.
Sam Altman takes his ‘io’ trademark battle public (theverge.com)
185.
OpenAI vs. ioY: Key takeaways from the new legal filings (9to5mac.com)
186.
Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs (gizmodo.com)
187.
Eli Lilly’s Obesity Pill Appears to Work as Well as Injected GLP-1s (wired.com)
188.
The FDA Just Approved a Long-Lasting Injection to Prevent HIV (wired.com)
189.
FDA Approves ‘Breakthough’ Drug to Prevent HIV (gizmodo.com)
190.
The Grug Brained Developer (2022) (news.ycombinator.com)
191.
Surgery Still Beats Ozempic and Other GLP-1 Drugs in Real-World Weight Loss Study (gizmodo.com)
192.
Threat in Your Medicine Cabinet: The FDA's Gamble on America's Drugs (news.ycombinator.com)
193.
A New Obesity Pill May Burn Fat Without Suppressing Appetite (wired.com)
194.
We found a germ that 'feeds' on hospital plastic – new study (news.ycombinator.com)
195.
The Download: gambling with humanity’s future, and the FDA under Trump (technologyreview.com)
196.
Here’s what food and drug regulation might look like under the Trump administration (technologyreview.com)
197.
The FDA Is Already Outsourcing Drug and Food Analysis to Error-Plagued AI Chatbot (futurism.com)
198.
Doctors Concerned By Massive Uptick In Teens Taking Ozempic (futurism.com)
199.
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage (cnbc.com)
Today's top topics: apple samsung zdnet android google amazon microsoft openai android authority windows 11
View all today's topics →